US FDA announces new program to boost domestic drug manufacturing
The program, called FDA PreCheck, aims to streamline review of domestic pharmaceutical manufacturing and eliminate unnecessary regulatory requirements, the FDA said
 "drugs, pharma")
The program also introduces a two-phase approach to facilitate new US drug manufacturing facilities.
Listen to This Article
The US Food and Drug Administration on Thursday announced a new program to strengthen the domestic pharmaceutical supply chain, by facilitating construction of manufacturing sites in the United States.
The program, called FDA PreCheck, aims to streamline review of domestic pharmaceutical manufacturing and eliminate unnecessary regulatory requirements, the FDA said.
The program also introduces a two-phase approach to facilitate new US drug manufacturing facilities.
More From This Section
 "Vladimir Putin, Putin")
 "US President Donald Trump")
 "switzerland")
 "Putin, Trump")
 "Donald trump, Tim Cook, glass plaque")
Don't miss the most important news and views of the day. Get them on our Telegram channel
First Published: Aug 07 2025 | 7:42 PM IST